Fingerprint
Dive into the research topics of 'Radiation therapy oncology group 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically